Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-07

Clinical Trial Update: Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP [Phase 2, Phase 3]

View source ↗

Summary

A neoadjuvant chemotherapy trial for pancreatic adenocarcinoma combining GS and GnP is in Phase 2/Phase 3 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GS
  • GnP

Snippet

Sponsor: Kochi University | Conditions: Pancreatic Adenocarcinoma | Phase 2, Phase 3 | Status: RECRUITING